Dynamk Capital
@dynamkvc
We work with pharma and biotech companies to accelerate start-ups in Life Sciences, providing critical technologies/services for vaccines and other therapeutics
ID: 4489990340
http://www.dynamk.vc 07-12-2015 21:35:04
226 Tweet
187 Followers
270 Following
📗 A study led by UChicago Obstetrics and Gynecology Department professor Dr. Ayman Al Hendy and colleagues recently explored ex vivo #exosome therapy models to pursue a novel, potentially safer alternative to hormone replacement therapy (HRT) for managing perimenopausal symptoms. mdpi.com/1422-0067/25/1…
RoosterBio Announces Collaboration with Thermo Fisher Scientific to Advance Cell and Exosome Therapy Manufacturing - bioinformant.com/roosterbio-col… RoosterBio Thermo Fisher